By Brian Amaral ( August 17, 2017, 12:54 PM EDT) -- Mylan will pay $465 million to resolve allegations that it ripped off the government by underpaying rebates for the EpiPen, federal authorities said Thursday, revealing for the first time that competitor Sanofi first blew the whistle in a False Claims Act suit....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.